Literature DB >> 15139517

Impact of tether length on bone mineral affinity of protein-bisphosphonate conjugates.

Sébastien A Gittens1, Pavel I Kitov, John R Matyas, Raimar Löbenberg, Hasan Uludağ.   

Abstract

PURPOSE: To determine the effect of tether length on bone mineral affinity of fetuin-bisphosphonate conjugates.
METHODS: 1-Amino-1,1-diphosphonate methane (aminoBP) was conjugated onto the lysine residues of fetuin by using five different crosslinkers that varied in length. Both the conjugation efficiency (i.e., the number of aminoBPs per protein) as well as molecular dynamics modeling of the resulting conjugates were assessed. Furthermore, the in vitro and in vivo bone mineral affinity of the conjugates were compared to one another.
RESULTS: The tethers, whose extended lengths varied from 5.7 to approximately 136 A, were effective in conjugating aminoBP onto fetuin. Molecular dynamics modeling revealed an inverse relationship between tether length and the maximal radial density of the pendent ligand. The capacity of the conjugates to bind to various bone matrices in vitro differed significantly, as aminoBPs tethered onto fetuin via shorter cross-linkers afforded a superior affinity for various mineral matrices than those tethered via longer cross-linkers. Results from the in vivo mineral implantation studies corroborated the in vitro findings, as higher binding was achieved with the shorter conjugates. Thus, the binding capacities of the conjugates paralleled the maximal radial densities of the pendent ligands.
CONCLUSIONS: The use of any of the chosen cross-linkers was feasible in conjugating aminoBP onto fetuin. Maximal mineral binding of the fetuin-aminoBP conjugates, however, was typically achieved using the shorter cross-linkers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15139517     DOI: 10.1023/b:pham.0000022407.05163.01

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  27 in total

1.  Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model.

Authors:  H Uludag; D D'Augusta; J Golden; J Li; G Timony; R Riedel; J M Wozney
Journal:  J Biomed Mater Res       Date:  2000-05

2.  Microdistribution of substratum-bound ligands affects cell function: hepatocyte spreading on PEO-tethered galactose.

Authors:  L G Griffith; S Lopina
Journal:  Biomaterials       Date:  1998-06       Impact factor: 12.479

3.  Direct measurement of a tethered ligand-receptor interaction potential.

Authors:  J Y Wong; T L Kuhl; J N Israelachvili; N Mullah; S Zalipsky
Journal:  Science       Date:  1997-02-07       Impact factor: 47.728

4.  alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling.

Authors:  Melanie Szweras; Danmei Liu; Emily A Partridge; Judy Pawling; Balram Sukhu; Cameron Clokie; Willi Jahnen-Dechent; Howard C Tenenbaum; Carol J Swallow; Marc D Grynpas; James W Dennis
Journal:  J Biol Chem       Date:  2002-03-18       Impact factor: 5.157

5.  Dose-dependent pharmacokinetics and disposition of bisphosphonic prodrug of diclofenac based on osteotropic drug delivery system (ODDS).

Authors:  Hideki Hirabayashi; Taiji Sawamoto; Jiro Fujisaki; Yuji Tokunaga; Sumihisa Kimura; Takehisa Hata
Journal:  Biopharm Drug Dispos       Date:  2002-11       Impact factor: 1.627

6.  The interaction of proteins with hydroxyapatite. II. Role of acidic and basic groups.

Authors:  M J Gorbunoff
Journal:  Anal Biochem       Date:  1984-02       Impact factor: 3.365

7.  Folate copolymer-mediated transfection of cultured cells.

Authors:  C P Leamon; D Weigl; R W Hendren
Journal:  Bioconjug Chem       Date:  1999 Nov-Dec       Impact factor: 4.774

8.  Bisphosphonate conjugation to proteins as a means to impart bone affinity.

Authors:  H Uludag; N Kousinioris; T Gao; D Kantoci
Journal:  Biotechnol Prog       Date:  2000 Mar-Apr

9.  Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged plasma circulation in vivo.

Authors:  Christopher M Ward; Michal Pechar; David Oupicky; Karel Ulbrich; Leonard W Seymour
Journal:  J Gene Med       Date:  2002 Sep-Oct       Impact factor: 4.565

10.  The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.

Authors:  Cora Schafer; Alexander Heiss; Anke Schwarz; Ralf Westenfeld; Markus Ketteler; Jurgen Floege; Werner Muller-Esterl; Thorsten Schinke; Willi Jahnen-Dechent
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

View more
  1 in total

1.  188Re-labelled gemcitabine/bisphosphonate (Gem/BP): a multi-functional, bone-specific agent as a potential treatment for bone metastases.

Authors:  Amal A El-Mabhouh; John R Mercer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-12       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.